The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Lymphadenopathy 22
SANDOSTATIN LAR DEPOT Proctalgia 22
SANDOSTATIN LAR DEPOT Pulmonary embolism 22
SANDOSTATIN Constipation 21
SANDOSTATIN Feeling abnormal 21
SANDOSTATIN Peripheral swelling 21
SANDOSTATIN LAR DEPOT Cataract 21
SANDOSTATIN LAR DEPOT Dry skin 21
SANDOSTATIN LAR DEPOT Haemorrhoids 21
SANDOSTATIN LAR DEPOT Hyperglycaemia 21
SANDOSTATIN LAR DEPOT Injection site haematoma 21
SANDOSTATIN LAR DEPOT Injection site scar 21
SANDOSTATIN LAR DEPOT Limb injury 21
SANDOSTATIN LAR DEPOT Lung infection 21
SANDOSTATIN LAR DEPOT Myalgia 21
SANDOSTATIN LAR DEPOT Neck pain 21
SANDOSTATIN LAR DEPOT Ocular hyperaemia 21
SANDOSTATIN LAR DEPOT Sepsis 21
SANDOSTATIN Blood glucose increased 20
SANDOSTATIN Erythema 20

Total Records: 2,045     Number of Pages: 103